ANI Pharmaceuticals Inc (ANIP): Share Repurchases
$12.21M
Year ended 2025-12-31
$22.22M
Trailing 12 months to 2026-06-30
+84.0%
3-year compound annual growth
+51.6%
5-year compound annual growth
| Period ended | Share Repurchases | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $12.21M | +11.4% | 2026-02-27, From 2025-01-01 |
| 2024-12-31 | $10.96M | +119.8% | 2026-02-27, From 2024-01-01 |
| 2023-12-31 | $4.99M | +154.6% | 2026-02-27, From 2023-01-01 |
| 2022-12-31 | $1.96M | +120.1% | 2025-02-28, From 2022-01-01 |
| 2021-12-31 | $890.0K | -41.6% | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | $1.52M | +47.7% | 2023-03-09, From 2020-01-01 |
| 2019-12-31 | $1.03M | n/a | 2022-03-15, From 2019-01-01 |
| 2018-12-31 | $0 | n/a | 2019-02-27, From 2018-01-01 |
| 2017-12-31 | $0 | -100.0% | 2019-02-27, From 2017-01-01 |
| 2016-12-31 | $2.50M | n/a | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | $0 | n/a | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $0 | -100.0% | 2017-03-02, From 2014-01-01 |
| 2013-12-31 | $433.0K | n/a | 2016-02-23, From 2013-01-01 |
| 2012-12-31 | $0 | n/a | 2014-02-28, From 2012-01-01 |
Share Repurchases at similar companies
| Company | Year ended | Share Repurchases | Change YoY |
|---|---|---|---|
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $12.21M | +11.4% |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $25.10M | -58.2% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $172.91M | n/m |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $24.90M | n/a |
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $148.33M | +493.3% |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 2025-12-31 | $75.59M | -11.6% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $156.28M | +203.4% |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $11.00M | -93.6% |
| Opko Health, Inc. (OPK) | 2025-12-31 | $47.04M | -47.9% |
Compare ANIP, COLL, CORT, EBS side by side · Screen every company in Pharmaceutical Preparations ↗